Balsalazide and mesalamine are aminosalicylate drugs (disease-modifying antirheumatic drugs) commonly used to treat ulcerative colitis by targeting peroxisome proliferator-activated receptor gamma (PPARG)61,79. Here, PPARG is linked to ulcerative colitis.